David M. Kaye

Active 1974–2026

Also published as
David M Kaye
234
Papers
32,351
Citations
104
h-index
223
i10-index

Citations

Citations per year for David M. Kaye1975: 2 citations1976: 4 citations1977: 4 citations1978: 1 citations1979: 1 citations1980: 2 citations1982: 1 citations1984: 2 citations1985: 1 citations1990: 1 citations1993: 3 citations1994: 2 citations1995: 15 citations1996: 38 citations1997: 56 citations1998: 50 citations1999: 90 citations2000: 90 citations2001: 92 citations2002: 72 citations2003: 116 citations2004: 92 citations2005: 124 citations2006: 110 citations2007: 144 citations2008: 174 citations2009: 179 citations2010: 178 citations2011: 162 citations2012: 234 citations2013: 197 citations2014: 232 citations2015: 245 citations2016: 240 citations2017: 169 citations2018: 218 citations2019: 843 citations2020: 975 citations2021: 1,011 citations2022: 899 citations2023: 712 citations2024: 1,224 citations2025: 694 citations2026: 16 citations1981: no citations, so this year is not shown1983: no citations, so this year is not shown1986–1989: no citations, so these years are not shown1991–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,185 citing papers, 22.6% of this breakdownChina: 1,142 citing papers, 8.1% of this breakdownUnited Kingdom: 966 citing papers, 6.8% of this breakdownAustralia: 921 citing papers, 6.5% of this breakdownGermany: 870 citing papers, 6.2% of this breakdownItaly: 761 citing papers, 5.4% of this breakdownCanada: 607 citing papers, 4.3% of this breakdownNetherlands: 567 citing papers, 4% of this breakdownFrance: 402 citing papers, 2.8% of this breakdownSpain: 392 citing papers, 2.8% of this breakdownJapan: 338 citing papers, 2.4% of this breakdownBelgium: 255 citing papers, 1.8% of this breakdown
0%22.6%Other 26.3%

Fields

  • Medicine69.5%
  • Biochemistry, Genetics and Molecular Biology17%
  • Neuroscience4.7%
  • Engineering3.5%
  • Nursing1.3%
  • Psychology0.8%
  • Other3.2%

Topics

  • Cardiovascular Function and Risk Factors6%
  • Heart Failure Treatment and Management3.8%
  • Heart Rate Variability and Autonomic Control3%
  • Gut microbiota and health2.8%
  • Atrial Fibrillation Management and Outcomes2.5%
  • Cardiac Imaging and Diagnostics2.1%
  • Other79.8%

Coauthors

All papers

Open in search
  1. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice

    Authors: , , , , , , , , , , , - Circulation 2016 cited by 1,055

  2. Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 403

  3. Sex differences in heart failure

    Authors: , , , , , , , , , - European Heart Journal 2019 cited by 779

  4. Alcohol Abstinence in Drinkers with Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 427

  5. Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 629

  6. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , - Circulation Research 2024 cited by 117

  7. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy

    Authors: , , , - Journal of the American College of Cardiology 2018 cited by 367

  8. Sex Differences in Cardiovascular Pathophysiology

    Authors: , , , , - Circulation 2018 cited by 492

  9. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Cavendish, Eugene Chung, Maja Cikes, Ira Dauber, Erwan Donal, Jean-Christophe Eicher, Peter Fail, James Flaherty, Xavier Freixa, Sameer Gafoor, Zachary Gertz, Robert Gordon, Marco Guazzi, Cesar Guerrero-Miranda, Deepak Gupta, Finn Gustafsson, Cyrus Hadadi, Emad Hakemi, Louis Handoko, Moritz Hass, Jorg Hausleiter, Christopher Hayward, Gavin Hickey, Scott Hummel, Imad Hussain, Richard Isnard, Chisato Izumi, Guillaume Jondeau, Elizabeth Juneman, Koichiro Kinugawa, Robert Kipperman, Bartek Krakowiak, Selim Krim, Joshua Larned, Gregory Lewis, Erik Lipsic, Anthony Magalski, Sula Mazimba, Jeremy Mazurek, Michele McGrady, Scott Mckenzie, Shamir Mehta, John Mignone, Hakim Morsli, Ajith Nair, Thomas Noel, James Orford, Kishan Parikh, Tiffany Patterson, Martin Penicka, Mark Petrie, Burkert Pieske, Martijn Post, Philip Raake, Alicia Romero, John Ryan, Yoshihiko Saito, Takafumi Sakamoto, Yasushi Sakata, Michael Samara, Kumar Satya, Andrew Sindone, Randall Starling, Jean-Noël Trochu, Bharathi Upadhya, Jan van der Heyden, Vanessa van Empel, Amit Varma, Amanda Vest, Tobias Wengenmayer and 4 more - The Lancet 2022 cited by 235

  10. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea

    Authors: , , , , , , , , , , , , , - JAMA Cardiology 2022 cited by 151

  11. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial

    Authors: , , , , , , , , , , , , - Nature Cardiovascular Research 2023 cited by 120

  12. The Gut Microbiome of Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , - Journal of the American Heart Association 2021 cited by 135

  13. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2023 cited by 104

  14. Beyond gut feelings: how the gut microbiota regulates blood pressure

    Authors: , , - Nature Reviews Cardiology 2017 cited by 402

  15. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kartik S. Sundareswaran, Edward G. Soltesz, Jerry D. Estep, ARIES-HM3 Investigators, Scott Silvestry, Antone Tatooles, Nasir Siulemanjee, Brett C. Sheridan, Sanjeev Gulati, Eugene S. Chung, Clément Delmas, Carmelo A. Milano, Pierre Dos Santos, Pavan Atluri, Douglas Horstmanshof, David A. D’Alessandro, Sriram Nathan, Peter Eckman, Anelechi Anyanwu, Anna Mara Scandroglio, Alessandro Ortalda, Ezequiel Molina, Jacob Abraham, Sern Lim, Robert Adamson, Ashwin Ravichandran, Chris Hayward, William Hiesinger, John W. Entwistle, Jennifer Conway, Eric Adler, Jonathan Grinstein, Andreas Brieke, Mary Keebler, Jeffrey D. Alexis, Igor Gošev, Craig H. Selzman, David M. Kaye - JAMA 2023 cited by 161

  16. Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways: A Multisite Analysis of Ambulatory Blood Pressure

    Authors: , , , , , , , , , , - Hypertension 2021 cited by 114

  17. New-onset atrial fibrillation prediction: the HARMS2-AF risk score

    Authors: , , , , , , , , , , , , , , - European Heart Journal 2023 cited by 75

  18. High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2009 cited by 459

  19. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2023 cited by 83

  20. The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank

    Authors: , , , , , , , , , , , - European Journal of Preventive Cardiology 2022 cited by 87

  21. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology

    Authors: , , , , , , , , , - JACC Heart Failure 2019 cited by 135

  22. An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score

    Authors: , , , , , , , , , , - Nature Medicine 2024 cited by 86

  23. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott D. Solomon, Jean-Noël Trochu, Dirk J. Van Veldhuisen, Ralf Westenfeld, Martin B. Leon, Sanjiv J. Shah, on behalf of the REDUCE LAP-HF-II Investigators - Circulation 2022 cited by 120

  24. Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , - Heart 2019 cited by 117